<p>达科塔财富管理在最近向证券交易委员会（SEC）披露的文件中表示，在第三季度将其在直觉外科公司（NASDAQ:ISRG - 免费报告）的股份减少了 63.9%。该基金在季度内出售了 8,291 股后，持有 4,692 股该医疗设备提供商的股票。截至其最近向证券交易委员会（SEC）提交的文件，达科塔财富管理在直觉外科的持股价值为 2,098,000 美元。</p>
<p>获取 <strong>Intuitive Surgical</strong> 警报：</p>
<ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股</li>
</ul>
<p>其他机构投资者最近也对该公司的持仓进行了调整。挪威银行在第二季度购买了价值 25,692,600,000 美元的直觉外科新股份。乐天投资管理公司在第三季度购买了价值约 388,436,000 美元的直觉外科新股份。先锋集团在第二季度将其在直觉外科的股份增加了 2.1%。先锋集团目前持有 33,335,833 股该医疗设备提供商的股票，价值为 18,115,025,000 美元，此前在上个季度又购买了 670,302 股。Jennison Associates LLC 在第二季度将其在直觉外科的股份增加了 20.4%。Jennison Associates LLC 目前持有 3,122,390 股该医疗设备提供商的股票，价值为 1,696,738,000 美元，此前在上个季度又购买了 528,359 股。最后，加拿大养老金计划投资委员会在第二季度将其在直觉外科的股份增加了 27.1%。加拿大养老金计划投资委员会目前持有 1,089,293 股该医疗设备提供商的股票，价值为 591,933,000 美元，此前在上个季度又购买了 231,980 股。机构投资者持有该公司 83.64% 的股份。</p>
<h2>Intuitive Surgical 股票上涨 2.5%</h2>
<p>直觉外科的股票周四开盘价为 506.17 美元。该公司的 50 日简单移动平均线为 532.31 美元，200 日简单移动平均线为 511.29 美元。直觉外科公司 12 个月低点为 425.00 美元，12 个月高点为 603.88 美元。该公司的市值为 1797.6 亿美元，市盈率为 64.15，市盈率增长比率为 3.83，贝塔值为 1.65。</p>
<ul>
<li>Intuitive Surgical 刚刚证明增长引擎仍在运转</li>
</ul>
<p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近一次发布财报是在 1 月 22 日，医疗设备提供商报告该季度每股收益为 2.53 美元，超出分析师一致预期的 2.27 美元，超出幅度为 0.26 美元。该季度的收入为 28.7 亿美元，而分析师预期为 27.2 亿美元。直觉外科的净利润率为 28.38%，股本回报率为 15.06%。直觉外科该季度的收入同比增长 18.8%。在去年同期，该公司每股收益为 2.21 美元。整体来看，卖方分析师预计直觉外科公司在当前财年将发布每股收益 6.43 美元。</p>
<h2>华尔街分析师观点</h2>
<p>多家券商对 ISRG 发表了评论。雷蒙德·詹姆斯金融公司将直觉外科的股票目标价从 603.00 美元上调至 615.00 美元，并在 1 月 23 日的研究报告中给予该公司 “跑赢大盘” 的评级。韦斯评级在 12 月 29 日的研究报告中重申了对直觉外科的 “持有（c+）” 评级。阿根斯将直觉外科的目标价从 630.00 美元下调至 560.00 美元，并在 2 月 4 日的研究报告中对该股票给予 “买入” 评级。花旗集团在 1 月 23 日的研究报告中重申了 “中性” 评级，并将直觉外科的目标价设定为 590.00 美元（低于 635.00 美元）。最后，罗伯特·W·贝尔德在 1 月 23 日的报告中将直觉外科的目标价从 655.00 美元下调至 645.00 美元，并对该股票给予 “跑赢大盘” 评级。两位研究分析师对该股票给予 “强烈买入” 评级，十五位给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 615.86 美元。</p>
<ul>
<li>2 只医疗股可能因财报而获得大幅提振</li>
</ul>
<p><strong>查看我们对直觉外科的最新分析</strong></p>
<h2>内部人士下注</h2>
<p>在相关消息中，SVP Mark Brosius 在 12 月 15 日的交易中出售了 464 股公司的股票，交易平均价格为 548.49 美元，总交易额为 254,499.36 美元。交易完成后，该高级副总裁在公司持有 131 股，价值为 71,852.19 美元。这代表其持股减少了 77.98%。该出售在与证券交易委员会的法律文件中披露，文件可通过此链接获取。此外，副总裁 Fredrik Widman 在 2 月 11 日的交易中出售了 133 股直觉外科的股票，平均价格为 494.96 美元，总交易额为 65,829.68 美元。交易完成后，该副总裁在公司持有 660 股，价值约为 326,673.60 美元。该交易代表其持股减少了 16.77%。该出售的披露在 SEC 文件中可获得。在过去 90 天内，内部人士共出售了价值 30,785,441 美元的 56,189 股公司股票。0.70% 的股票由公司内部人士持有。</p>
<h2>直觉外科公司简介</h2>
<p>（免费报告）</p>
<p>直觉外科成立于 1995 年，总部位于加利福尼亚州的阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗科技公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉外科的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室内的精确度、可视化和控制能力。</p>
<p>除了核心手术平台外，直觉外科还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
<h2>另请参见</h2>
<ul>
<li>我们更看好的五只股票，胜过直觉外科</li>
<li>揭示：白宫背后发生的大事</li>
<li>警报：在明天市场开盘前抛售这五只股票！</li>
<li>埃隆·马斯克：这可能将 100 美元变成 100,000 美元</li>
<li>阅读此文，否则将永远后悔</li>
<li>下一个商品危机（比石油还大？）</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
<p>在考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

标普健康医疗设备 ETF - SPDR

美国医药设备 ETF - iShares

UTRS

直觉外科

ASXC

ISUL

<p>Dakota Wealth Management 在第三季度减少了对 Intuitive Surgical, Inc. (NASDAQ: ISRG) 的持股比例，降幅为 63.9%，目前持有 4,692 股，市值为 210 万美元。其他机构投资者，包括挪威银行和先锋集团，也调整了他们的持仓。Intuitive Surgical 的股票上涨了 2.5%，开盘价为 506.17 美元，市值为 1797.6 亿美元。该公司报告每股收益为 2.53 美元，超出预期，营收同比增长 18.8%。分析师维持 “适度买入” 的共识评级，平均目标价为 615.86 美元</p>

<p>Dakota Wealth Management cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 63.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,692 shares of the medical equipment provider's stock after selling 8,291 shares during the quarter. Dakota Wealth Management's holdings in Intuitive Surgical were worth $2,098,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>达科塔财富管理在最近向证券交易委员会（SEC）披露的文件中表示，在第三季度将其在直觉外科公司（NASDAQ:ISRG - 免费报告）的股份减少了 63.9%。该基金在季度内出售了 8,291 股后，持有 4,692 股该医疗设备提供商的股票。截至其最近向证券交易委员会（SEC）提交的文件，达科塔财富管理在直觉外科的持股价值为 2,098,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 警报：</p>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股</li>
</ul>
</div><p>Other institutional investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in Intuitive Surgical in the second quarter worth $2,569,260,000. Rakuten Investment Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth about $388,436,000. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock valued at $18,115,025,000 after purchasing an additional 670,302 shares during the last quarter. Jennison Associates LLC increased its position in shares of Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider's stock valued at $1,696,738,000 after purchasing an additional 528,359 shares during the last quarter. Finally, Canada Pension Plan Investment Board lifted its position in Intuitive Surgical by 27.1% in the 2nd quarter. Canada Pension Plan Investment Board now owns 1,089,293 shares of the medical equipment provider's stock worth $591,933,000 after buying an additional 231,980 shares during the last quarter. Institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者最近也对该公司的持仓进行了调整。挪威银行在第二季度购买了价值 25,692,600,000 美元的直觉外科新股份。乐天投资管理公司在第三季度购买了价值约 388,436,000 美元的直觉外科新股份。先锋集团在第二季度将其在直觉外科的股份增加了 2.1%。先锋集团目前持有 33,335,833 股该医疗设备提供商的股票，价值为 18,115,025,000 美元，此前在上个季度又购买了 670,302 股。Jennison Associates LLC 在第二季度将其在直觉外科的股份增加了 20.4%。Jennison Associates LLC 目前持有 3,122,390 股该医疗设备提供商的股票，价值为 1,696,738,000 美元，此前在上个季度又购买了 528,359 股。最后，加拿大养老金计划投资委员会在第二季度将其在直觉外科的股份增加了 27.1%。加拿大养老金计划投资委员会目前持有 1,089,293 股该医疗设备提供商的股票，价值为 591,933,000 美元，此前在上个季度又购买了 231,980 股。机构投资者持有该公司 83.64% 的股份。</p>
</div><h2>Intuitive Surgical Stock Up 2.5%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票上涨 2.5%</h2>
</div><p>Shares of Intuitive Surgical stock opened at $506.17 on Thursday. The company's fifty day simple moving average is $532.31 and its two-hundred day simple moving average is $511.29. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The firm has a market cap of $179.76 billion, a PE ratio of 64.15, a price-to-earnings-growth ratio of 3.83 and a beta of 1.65.</p>
<div class="lb-trans"><p>直觉外科的股票周四开盘价为 506.17 美元。该公司的 50 日简单移动平均线为 532.31 美元，200 日简单移动平均线为 511.29 美元。直觉外科公司 12 个月低点为 425.00 美元，12 个月高点为 603.88 美元。该公司的市值为 1797.6 亿美元，市盈率为 64.15，市盈率增长比率为 3.83，贝塔值为 1.65。</p>
</div><ul>
<li>Intuitive Surgical Just Proved the Growth Engine Still Runs</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 刚刚证明增长引擎仍在运转</li>
</ul>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical's revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.21 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近一次发布财报是在 1 月 22 日，医疗设备提供商报告该季度每股收益为 2.53 美元，超出分析师一致预期的 2.27 美元，超出幅度为 0.26 美元。该季度的收入为 28.7 亿美元，而分析师预期为 27.2 亿美元。直觉外科的净利润率为 28.38%，股本回报率为 15.06%。直觉外科该季度的收入同比增长 18.8%。在去年同期，该公司每股收益为 2.21 美元。整体来看，卖方分析师预计直觉外科公司在当前财年将发布每股收益 6.43 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of brokerages have commented on ISRG. Raymond James Financial increased their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, January 23rd. Weiss Ratings reaffirmed a &#34;hold (c+)&#34; rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Argus decreased their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, February 4th. Citigroup restated a &#34;neutral&#34; rating and set a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $655.00 to $645.00 and set an &#34;outperform&#34; rating on the stock in a report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $615.86.</p>
<div class="lb-trans"><p>多家券商对 ISRG 发表了评论。雷蒙德·詹姆斯金融公司将直觉外科的股票目标价从 603.00 美元上调至 615.00 美元，并在 1 月 23 日的研究报告中给予该公司 “跑赢大盘” 的评级。韦斯评级在 12 月 29 日的研究报告中重申了对直觉外科的 “持有（c+）” 评级。阿根斯将直觉外科的目标价从 630.00 美元下调至 560.00 美元，并在 2 月 4 日的研究报告中对该股票给予 “买入” 评级。花旗集团在 1 月 23 日的研究报告中重申了 “中性” 评级，并将直觉外科的目标价设定为 590.00 美元（低于 635.00 美元）。最后，罗伯特·W·贝尔德在 1 月 23 日的报告中将直觉外科的目标价从 655.00 美元下调至 645.00 美元，并对该股票给予 “跑赢大盘” 评级。两位研究分析师对该股票给予 “强烈买入” 评级，十五位给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 615.86 美元。</p>
</div><ul>
<li>2 Healthcare Names That Could Get a Big Boost From Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只医疗股可能因财报而获得大幅提振</li>
</ul>
</div><p><strong>View Our Latest Analysis on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们对直觉外科的最新分析</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, SVP Mark Brosius sold 464 shares of the company's stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the completion of the transaction, the senior vice president owned 131 shares in the company, valued at $71,852.19. This represents a 77.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 56,189 shares of company stock valued at $30,785,441 in the last 90 days. 0.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，SVP Mark Brosius 在 12 月 15 日的交易中出售了 464 股公司的股票，交易平均价格为 548.49 美元，总交易额为 254,499.36 美元。交易完成后，该高级副总裁在公司持有 131 股，价值为 71,852.19 美元。这代表其持股减少了 77.98%。该出售在与证券交易委员会的法律文件中披露，文件可通过此链接获取。此外，副总裁 Fredrik Widman 在 2 月 11 日的交易中出售了 133 股直觉外科的股票，平均价格为 494.96 美元，总交易额为 65,829.68 美元。交易完成后，该副总裁在公司持有 660 股，价值约为 326,673.60 美元。该交易代表其持股减少了 16.77%。该出售的披露在 SEC 文件中可获得。在过去 90 天内，内部人士共出售了价值 30,785,441 美元的 56,189 股公司股票。0.70% 的股票由公司内部人士持有。</p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>直觉外科公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直觉外科成立于 1995 年，总部位于加利福尼亚州的阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗科技公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉外科的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室内的精确度、可视化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手术平台外，直觉外科还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参见</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>REVEALED: Something Big Happening Behind White House Doors</li>
<li>ALERT: Drop these 5 stocks before the market opens tomorrow!</li>
<li>Elon Musk: This Could Turn $100 into $100,000</li>
<li>Read this or regret it forever</li>
<li>The Next Commodity Crunch (bigger than oil?)</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过直觉外科</li>
<li>揭示：白宫背后发生的大事</li>
<li>警报：在明天市场开盘前抛售这五只股票！</li>
<li>埃隆·马斯克：这可能将 100 美元变成 100,000 美元</li>
<li>阅读此文，否则将永远后悔</li>
<li>下一个商品危机（比石油还大？）</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Dakota Wealth Management Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Market Beat

Minerva Surgical

Asensus Surgical

GraniteShares 2x Long ISRG Daily ETF

Dakota Wealth Management 减少了其在直觉外科公司（Intuitive Surgical, Inc. $ISRG）的股票持仓